Eyes Are on Watchman, Niacin

ACC 2013 — SAN FRANCISCO — The Watchman left atrial appendage closure device and details from a failed niacin trial will be in the spotlight when the American College of Cardiology meeting kicks off Saturday.

Keywords: AHA Annual Scientific Sessions


< Back to Listings